Topic Editors

IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, 47014 Meldola, FC, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, 47014 Meldola, Italy

Myeloma and Leukemia—Challenges and Current Treatment Options: 2nd Edition

Abstract submission deadline
18 June 2026
Manuscript submission deadline
18 September 2026
Viewed by
15

Topic Information

Dear Colleagues,

This Topic is the second edition of the collection “Myeloma and Leukemia—Challenges and Current Treatment Options”, available at https://www.mdpi.com/topics/LCACTO.

After years of stagnation in the field, in recent years, we have entered into a new era in multiple myeloma and acute leukemia therapy with the discovery of many novel agents. This was due to better knowledge of the biology of the diseases, and of the pathogenesis-related pathways, with the advent of new combinations of drugs and new therapy development, together with an improved understanding of the immune system, resulting in great progress in the development of immune therapies for the treatment of patients, including monoclonal and bispecific antibodies, and CAR-T cell approaches. The numerous ongoing trials evaluating these new opportunities, also considering real-life experiences, are helping to confirm the efficacy and tolerability of these drugs in daily clinical practice. This Special Issue aims to focus on novel agents and their combinations. Focus will be placed on the efficacy of novel drugs and promising combination approaches to further improve outcomes in the treatment of patients with multiple myeloma and acute leukemia. 

We welcome the submission of original research articles, reviews, interesting case reports, and interim data of clinical trials.

 

Dr. Giovanni Martinelli
Dr. Claudio Cerchione


 

Dr. Giovanni Martinelli
Dr. Claudio Cerchione
Topic Editors

Keywords

• acute leukemia; • acute myeloid leukemia; • acute lymphoblastic leukemia; • novel agents; • target therapy; • CAR-T cellular therapy

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
BioMedInformatics
biomedinformatics
- 3.4 2021 22.9 Days CHF 1000 Submit
Cancers
cancers
4.4 8.8 2009 20.3 Days CHF 2900 Submit
Hemato
hemato
1.0 2.0 2020 33.8 Days CHF 1200 Submit
Hematology Reports
hematolrep
1.2 1.4 2009 26.9 Days CHF 1600 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers

This Topic is now open for submission.
Back to TopTop